Clinical Trial Update: Acitretin Plasma Levels Under Hemodialysis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating acitretin plasma levels during hemodialysis for squamous cell carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma

Drugs mentioned

• Acitretin (Acitretin)

Snippet

Sponsor: Günther Hofbauer | Conditions: Carcinoma, Squamous Cell | Phase 4 | Status: WITHDRAWN